Wednesday, December 28, 2005
U.S. FDA approves new nasal flu vaccine plant, MedImmune Inc. says
WASHINGTON (AP) - The American pharmaceutical company MedImmune Inc. expects to ramp up production of FluMist nasal flu vaccine next year after a newly built plant it owns in England received FDA approval, the company said Tuesday. The U.S....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment